An ambitious, world-class cancer research facility is to be built at The Christie on the site of the Paterson building in Manchester. It was the site which suffered devastating fire damage in April 2017 displacing over 300 scientists and support staff.
It will integrate researchers and clinicians in a new state-of-the-art building. The experts will develop new ways to conduct team science approaches to accelerate the translation and adoption of research into the clinic.
This approach will ensure that Manchester remains at the international forefront of research in this field.
The multi-million-pound development will be led by The Christie on behalf of the Manchester Cancer Research Centre (MCRC).
The partners believe this exciting development embraces a great opportunity to transform the disaster of the Paterson building fire into a bold and exciting future. Detailed work to secure necessary formal approvals will be undertaken over the coming months.
In addition to housing the Cancer Research UK Manchester Institute, the new development will be a major step forward in realising MCRC’s ambition of becoming one of the world’s top five centres for basic, translational and clinical cancer research.
Manchester is already a world scientific lead in cancer biomarkers, the molecular targeting of cancer, early-phase clinical trials and cutting-edge radiotherapy, including the opening of one of only two NHS high energy proton beam therapy centres in the UK later this year.
The new building will also harness the potential of healthcare research within a catchment area of three million people as part of the Greater Manchester Cancer plan and Health Innovation Manchester.
Roger Spencer, Chief Executive of The Christie NHS Foundation Trust, said: “It will ensure our patients receive access to the latest personalised and innovative cancer treatments.”
Detailed planning for the building is underway with a goal for completion in early 2021.
Photo Credit: Herney